{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:26:47Z","timestamp":1790267207604,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Center","award":["NCC 2510490-1"],"award-info":[{"award-number":["NCC 2510490-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05267-8","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:32:44Z","timestamp":1767486764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Re-evaluation of cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis based on radiological features, patient symptoms\/signs, and clinical follow-up"],"prefix":"10.1007","volume":"176","author":[{"given":"Yun-Sik","family":"Dho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Shin","family":"Gwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"5267_CR1","first-page":"345","volume":"51","author":"O Babusikova","year":"2004","unstructured":"Babusikova O, Zeleznikova T (2004) The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia\/lymphoma cells. Neoplasma 51:345\u2013351","journal-title":"Neoplasma"},{"key":"5267_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3340\/jkns.2015.58.1.1","volume":"58","author":"HS Gwak","year":"2015","unstructured":"Gwak HS, Lee SH, Park WS, Shin SH, Yoo H, Lee SH (2015) Recent advancements of treatment for leptomeningeal carcinomatosis. J Korean Neurosurg Soc 58:1\u20138. https:\/\/doi.org\/10.3340\/jkns.2015.58.1.1","journal-title":"J Korean Neurosurg Soc"},{"key":"5267_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","volume":"82","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters BC, Recht LD (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82:733\u2013739","journal-title":"Cancer"},{"key":"5267_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/neuonc\/noy186","volume":"21","author":"L Angus","year":"2019","unstructured":"Angus L, Martens JWM, van den Bent MJ, Sillevis Smitt PAE, Sleijfer S, Jager A (2019) Novel methods to diagnose leptomeningeal metastases in breast cancer. Neuro Oncol 21:428\u2013439. https:\/\/doi.org\/10.1093\/neuonc\/noy186","journal-title":"Neuro Oncol"},{"key":"5267_CR5","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","volume":"29","author":"JP Glass","year":"1979","unstructured":"Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369\u20131375","journal-title":"Neurology"},{"key":"5267_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/neuonc\/now183","volume":"19","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, Junck L, Brandsma D, Soffietti R, Ruda R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Walker J, van den Bent M, Wen PY, Jaeckle KA (2017) Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol 19:484\u2013492. https:\/\/doi.org\/10.1093\/neuonc\/now183","journal-title":"Neuro Oncol"},{"key":"5267_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s004150050459","volume":"246","author":"CS Straathof","year":"1999","unstructured":"Straathof CS, de Bruin HG, Dippel DW, Vecht CJ (1999) The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 246:810\u2013814","journal-title":"J Neurol"},{"key":"5267_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1023\/A:1005783507544","volume":"36","author":"JM Gomori","year":"1998","unstructured":"Gomori JM, Heching N, Siegal T (1998) Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging. J Neurooncol 36:55\u201360","journal-title":"J Neurooncol"},{"key":"5267_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/BF00588709","volume":"35","author":"M Watanabe","year":"1993","unstructured":"Watanabe M, Tanaka R, Takeda N (1993) Correlation of MRI and clinical features in meningeal carcinomatosis. Neuroradiology 35:512\u2013515","journal-title":"Neuroradiology"},{"key":"5267_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11060-019-03190-3","volume":"143","author":"Y Ko","year":"2019","unstructured":"Ko Y, Gwak HS, Park EY, Joo J, Lee YJ, Lee SH, Kwon JW, Shin SH, Yoo H (2019) Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer. J Neurooncol 143:553\u2013562. https:\/\/doi.org\/10.1007\/s11060-019-03190-3","journal-title":"J Neurooncol"},{"key":"5267_CR11","doi-asserted-by":"publisher","first-page":"iv84","DOI":"10.1093\/annonc\/mdx221","volume":"28","author":"E Le Rhun","year":"2017","unstructured":"Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P, Ruda R, Preusser M, Board EE, Committee EG (2017) EANO-ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol 28:iv84\u2013iv99. https:\/\/doi.org\/10.1093\/annonc\/mdx221","journal-title":"Ann Oncol"},{"key":"5267_CR12","doi-asserted-by":"publisher","unstructured":"Le Rhun E, Devos P, Boulanger T, Smits M, Brandsma D, Ruda R, Furtner J, Hempel JM, Postma TJ, Roth P, Snijders TJ, Winkler F, Winklhofer S, Castellano A, Hattingen E, Capellades J, Gorlia T, Van den Bent M, Wen PY, Bendszus M, Weller M (2019) European organisation for R, Treatment of cancer brain tumor group central nervous system metastases C, the EBTGIC The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: Lack of feasibility and clinical utility and a revised proposal. Neuro Oncol 21: 648\u2013658 https:\/\/doi.org\/10.1093\/neuonc\/noz024","DOI":"10.1093\/neuonc\/noz024"},{"key":"5267_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ana.410380111","volume":"38","author":"RJ Freilich","year":"1995","unstructured":"Freilich RJ, Krol G, DeAngelis LM (1995) Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38:51\u201357","journal-title":"Ann Neurol"},{"key":"5267_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/CCO.0b013e32833de986","volume":"22","author":"MC Chamberlain","year":"2010","unstructured":"Chamberlain MC (2010) Leptomeningeal metastasis. Curr Opin Oncol 22:627\u2013635","journal-title":"Curr Opin Oncol"},{"key":"5267_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/neuonc\/noz012","volume":"21","author":"A Boire","year":"2019","unstructured":"Boire A, Brandsma D, Brastianos PK, Le Rhun E, Ahluwalia M, Junck L, Glantz M, Groves MD, Lee EQ, Lin N, Raizer J, Ruda R, Weller M, Van den Bent MJ, Vogelbaum MA, Chang S, Wen PY, Soffietti R (2019) Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro Oncol 21:571\u2013584. https:\/\/doi.org\/10.1093\/neuonc\/noz012","journal-title":"Neuro Oncol"},{"key":"5267_CR16","doi-asserted-by":"publisher","first-page":"vdad002","DOI":"10.1093\/noajnl\/vdad002","volume":"5","author":"Y Nakasu","year":"2023","unstructured":"Nakasu Y, Deguchi S, Nakasu S, Yamazaki M, Notsu A, Mitsuya K, Hayashi N (2023) Diagnostic accuracy of cerebrospinal fluid liquid biopsy and MRI for leptomeningeal metastases in solid cancers: A systematic review and meta-analysis. Neurooncol Adv 5:vdad002. https:\/\/doi.org\/10.1093\/noajnl\/vdad002","journal-title":"Neurooncol Adv"},{"key":"5267_CR17","doi-asserted-by":"publisher","first-page":"73312","DOI":"10.18632\/oncotarget.20272","volume":"8","author":"G Nayar","year":"2017","unstructured":"Nayar G, Ejikeme T, Chongsathidkiet P, Elsamadicy AA, Blackwell KL, Clarke JM, Lad SP, Fecci PE (2017) Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget 8:73312\u201373328. https:\/\/doi.org\/10.18632\/oncotarget.20272","journal-title":"Oncotarget"},{"key":"5267_CR18","doi-asserted-by":"publisher","first-page":"v86","DOI":"10.1093\/noajnl\/vdab108","volume":"3","author":"U Sener","year":"2021","unstructured":"Sener U, Kumthekar P, Boire A (2021) Advances in the diagnosis, evaluation, and management of leptomeningeal disease. Neurooncol Adv 3:v86\u2013v95. https:\/\/doi.org\/10.1093\/noajnl\/vdab108","journal-title":"Neurooncol Adv"},{"key":"5267_CR19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1200\/JCO.1999.17.6.1825","volume":"17","author":"A Gajjar","year":"1999","unstructured":"Gajjar A, Fouladi M, Walter AW, Thompson SJ, Reardon DA, Merchant TE, Jenkins JJ, Liu A, Boyett JM, Kun LE, Heideman RL (1999) Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. J Clin Oncol 17:1825\u20131828. https:\/\/doi.org\/10.1200\/JCO.1999.17.6.1825","journal-title":"J Clin Oncol"},{"key":"5267_CR20","first-page":"1757","volume":"21","author":"SP Meyers","year":"2000","unstructured":"Meyers SP, Wildenhain SL, Chang JK, Bourekas EC, Beattie PF, Korones DN, Davis D, Pollack IF, Zimmerman RA (2000) Postoperative evaluation for disseminated Medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes. AJNR Am J Neuroradiol 21:1757\u20131765","journal-title":"AJNR Am J Neuroradiol"},{"key":"5267_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-023-04334-2","volume":"163","author":"VM Lu","year":"2023","unstructured":"Lu VM, Abou-Al-Shaar H, Bin-Alamer O, Luther EM, Benjamin CG (2023) Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal disease: a systematic review, meta-analysis, and meta-regression with an illustrative case. J Neurooncol 163:29\u201337. https:\/\/doi.org\/10.1007\/s11060-023-04334-2","journal-title":"J Neurooncol"},{"key":"5267_CR22","doi-asserted-by":"publisher","unstructured":"Chamberlain MC, Kormanik P (1998) Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy. Arch Neurol 55:506\u2013512. https:\/\/doi.org\/10.1001\/archneur.55.4.506","DOI":"10.1001\/archneur.55.4.506"},{"key":"5267_CR23","doi-asserted-by":"publisher","unstructured":"Gwak HS, Joo J, Kim S, Yoo H, Shin SH, Han JY, Kim HT, Lee JS, Lee SH (2013) Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer. J Thorac Oncol 8:599\u2013605. https:\/\/doi.org\/10.1097\/JTO.0b013e318287c943","DOI":"10.1097\/JTO.0b013e318287c943"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05267-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05267-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:47:01Z","timestamp":1769773621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05267-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5267"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05267-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of National Cancer Center approved this study (Approval no. NCC2022-0305).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed patient was not required according to the Ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}